Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Herbal Medicines Showing Synergistic Effects with Tumor Necrosis Factor‑Related Apoptosis‑Inducing Ligand (TRAIL) against A549 TRAIL‑resistant Lung Cancer Cells: A Screening Study

    Shuen Cheng Chiang2, Yeon‑Jung Choi2, Shi‑Eun Kang3, Miyong Yun4, Beom‑Joon Lee2,5★★ Corresponding author

    1. 1Department of Clinical Korean Medicine, Graduate School, Kyung Hee University.
    2. 2Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University.
    3. 3Department of Bioindustry and Bioresource Engineering, College of Life Sciences, Sejong University.
    4. 4Department of Internal Medicine (Pulmonary and Allergy System), Korean Medicine Hospital, Seoul, Republic of Korea.

    CORRESPONDENCE

    Beom‑Joon Lee

    Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University.

    franchisjun@naver.com

    Received: 25-06-2017; Revised: 16-08-2017.

    Volume 14, Issue 54 · pp. 145–148 · PUBLISHED 10 April 2018 · DOI: 10.4103/pm.pm_270_17

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Tumor necrosis factor‑related apoptosis‑inducing ligand (TRAIL) is a cytokine that activates apoptosis through death receptors on the cell surface and is regarded as a potential anticancer agent. However, many cancer cells are resistant to TRAIL‑induced apoptosis. Objective: The aim is to identify the herbal medicines that could help overcome resistance in TRAIL‑resistant lung cancer cells. Materials and Methods; TRAIL‑resistant A549 cells and 13 herbal medicines with known apoptosis‑related anticancer effects were used in this study: Clematidis Radix, Corydalis Tuber Rhizoma, Paeoniae Radix Rubra, Corni Fructus, Curcumae longae Rhizoma (CLR), Moutan Cortex, Salviae miltiorrhizae Radix, Phellodendri Cortex, Farfarae Flos, Paeoniae Radix Alba, Angelicae gigantis Radix, Coptidis Rhizoma (CR), and Taraxaci Herba. Cytotoxic effects were investigated after a 48‑h incubation, using an 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyl tetrazolium bromide assay, to identify the herbal medicines with the most potent synergistic effects with TRAIL. Results: The majority of the 13 medicines exhibited concentration‑dependent cytotoxicity against A549 cells. Among them, CR and CLR showed the most potent cytotoxic effects, based on the IC50. We then investigated the use of these two medicines in combination with TRAIL and identified synergistic cytotoxic effects against TRAIL‑resistant A549 cells. Conclusion: Synergistic cytotoxic effects of the combination of TRAIL and herbal medicines, in particular, CR and CLR, were confirmed in A549 cells. Therefore, CR and CLR showed potential to be used as candidates to overcome TRAIL resistance. Future studies to identify their underlying mechanism of action are required.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Chiang, S. C., Choi, Y., Kang, S., Yun, M., & Lee, B. (2018). Herbal Medicines Showing Synergistic Effects with Tumor Necrosis Factor‑Related Apoptosis‑Inducing Ligand (TRAIL) against A549 TRAIL‑resistant Lung Cancer Cells: A Screening Study. Pharmacognosy Magazine, 14(54), 145–148. https://doi.org/10.4103/pm.pm_270_17